Search
for
Sort by
Research 991–1000 of 1000+
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- 1108 Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Alopecia Areata
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience